Shennon Biotechnologies
Develops a single-cell platform for rapid immunotherapy drug discovery.
biotechpharmaceuticals
Company facts
Seed-stage
- Founded
- 2021
- Employees
- 16
- Headquarters
- United States
- Type
- Private
- Funding
- Seed · $13M · 2023
Open positions
1 job
28 views 2 weeks ago
Scientist/Senior Scientist in T-cell Engager (TCE) Development
Open 139d North AmericaSenior 2 questions
United States
San Francisco, CAWe are a well-funded biotech company that is redefining biologics discovery and development through our fully integrated platform. We combine ultra-high-throughput microfluidics driven functional screening,…